Pharmafile Logo

Dedicated

- PMLiVE

Pressure put on Roche to cut Kadcyla’s UK price

30,000 people sign petition to help make the breast cancer drug available on the NHS

- PMLiVE

Pharma lobbying in the US

Is it a matter of freedom of speech?

Novartis building

FDA panel backs Novartis’ secukinumab for psoriasis

Drug has outperformed Amgen’s Enbrel in clinical trials

- PMLiVE

AbbVie and Shire bring merger plans to a close

Blames tax changes in the US

- PMLiVE

EMA offers orphan drug benefits for Ebola research

Incentives to encourage development of new treatments for the virus

- PMLiVE

Salary survey now open – how will you measure up?

Take part for a chance to win a Kindle Fire HD tablet

- PMLiVE

Parkinson’s UK appoints Arthur Roach as research director

He brings experience from Merck Serono and the Geneva Pharma Network

- PMLiVE

Red Door promotes Matt Lowe and Katy Pogson

Kate Aldous and Sarah Aldridge also move up at the Creston Health agency

- PMLiVE

Janssen’s blood cancer drug Imbruvica approved in Europe

European commission licenses the first-in-class drug for two rare diseases

- PMLiVE

Regeneron top science employer, says survey

Ranked highest for third year in a row

- PMLiVE

FDA votes to keep severe warning on Pfizer’s Chantix

Will not relax anti-smoking drug's side effect warning

Kantar Health adds to UK team

Group director, junior designers and graduate research team appointed

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links